Finance

Beta
Lists
SVA:TSE
Sernova Biotherapeutics Inc
CA$0.15
-6.25%
(-0.0100) 1D
Jun 19, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for SVA...
Open
CA$0.15
High
CA$0.15
Low
CA$0.12
Mkt. cap
56.79M
Avg. vol.
122.41K
Volume
394.47K
52-wk high
CA$0.21
52-wk low
CA$0.12
EPS
-CA$0.04
Beta
30.45
Shares outstanding
377.64M
No. of employees
8
Open
CA$0.15
High
CA$0.15
Low
CA$0.12
Mkt. cap
56.79M
Avg. vol.
122.41K
Volume
394.47K
52-wk high
CA$0.21
52-wk low
CA$0.12
EPS
-CA$0.04
Beta
30.45
Shares outstanding
377.64M
No. of employees
8
News stories
From sources across the web
About Sernova Biotherapeutics Inc
CEOJonathan Rigby
Employees8
Founded2006
HeadquartersLondon, Ontario, Canada
SectorBiotechnology
Websitesernova.com
Last report
Jun 11, 2026
Fiscal period
Q2 2026
EPS / Est. (CAD)
-CA$0.01 / -CA$0.01
0.00%miss
Revenue / Est. (CAD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.74M
809.63K
434.15K
444.87K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.76M
1.59M
1.68M
1.85M
Operating expense
3.50M
2.40M
2.12M
2.30M
Total operating expenses
3.50M
2.40M
2.12M
2.30M
Operating income
-3.50M
-2.40M
-2.12M
-2.30M
Other non operating income
-
-
-
-
EBT including unusual items
-4.05M
-2.25M
-2.41M
-3.23M
EBT excluding unusual items
-4.10M
-2.26M
-2.41M
-3.23M
Income tax expense
21.12K
-54.97K
-72.00K
-
Effective tax rate
-0.52%
2.44%
2.99%
-
Other operating expenses
-
-
-
-
Net income
-4.07M
-2.20M
-2.33M
-3.23M
Net profit margin
-
-
-
-
Earnings per share
-0.01
-0.01
-0.01
-0.01
Interest and investment income
131.00
260.60K
-
413.00
Interest expense
-541.68K
-
-477.12K
-920.95K
Net interest expenses
-541.54K
260.60K
-477.12K
-920.53K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.40M
-2.34M
-2.11M
-2.29M
Gain or loss from assets sale
-50.96K
-4.25K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer